share_log

EV Biologics Briefs Shareholders on Market Cap Peer Comparison

EV Biologics Briefs Shareholders on Market Cap Peer Comparison

EV Biologics向股東介紹市值同行比較
accesswire ·  2021/08/12 13:00

Published: 08/12/2021YECO

發佈日期:08/12/2021YECO

NASHVILLE, TN / ACCESSWIRE / August 12, 2021 / EV Biologics Corp, OTC Pink:YECO, today briefed shareholders on its current value compared to other public biotechnology companies in its peer group.

田納西州納什維爾/ACCESSWIRE/2021年8月12日/EV Biologics Corp(場外交易市場代碼:YECO)今天向股東簡要介紹了與其同行中的其他上市生物技術公司相比,該公司目前的價值。

Please view the chart at:https://www.evbiologics.com/marketcap/.

請瀏覽圖表:https://www.evbiologics.com/marketcap/.

CEO Daniel Mckinney commented: 'Our market cap is less than half that of our closest listed peer. Our goal is to continue to build value and become the largest listed company by market cap in our space within the next 24 months. This...

首席執行官丹尼爾·麥金尼(Daniel McKinney)評論説:“我們的市值不到最接近的上市同行的一半。我們的目標是繼續創造價值,並在未來24個月內成為我們領域市值最大的上市公司。這……

20210812220338264d1977ysav4rdiy6

Read more: EV Biologics Corporation

閲讀更多內容:EV生物製品公司

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論